Evaluation of Therapeutic Management in ESBL-infected Patients or Carriers by Providing and Sharing a Free Tool - the "ESBL toolKIT"and Interventional Study of a Prospective Cohort of HIV+ Patients Searching for Possible Sexual Transmission Factors in ESBL Carriers
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE NICE · Dec 10, 2013
Trial Information
Current as of May 12, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age \> 18
- • HIV+ patient of the hospital's outpatient clinic
- • Signature of informed consent
- • Affiliation of the Social Security system
- • Exclusion criteria
- • Vulnerable Persons: minor patient, wardship (tutelage), no liberty to act and speak
- • Pregnancy and lactation: a urine pregnancy test will be performed for women of childbearing age. Results will be reported by the physician selected by the patient
About Centre Hospitalier Universitaire De Nice
The Centre Hospitalier Universitaire (CHU) de Nice is a leading academic medical center located in Nice, France, dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, CHU de Nice is committed to enhancing patient care by conducting rigorous studies that explore new therapies and treatment modalities across various medical disciplines. With a focus on collaboration, the center integrates cutting-edge technology and interdisciplinary expertise to ensure the highest standards of research integrity and patient safety. CHU de Nice plays a vital role in the development of evidence-based medicine, contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nice, Alpes Maritimes, France
Patients applied
Trial Officials
MONDAIN Véronique, Ph
Principal Investigator
Service d'Infectiologie - Hôpital Archet - 151 route St Ginestière - 06 202 Nice
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials